HomeAI · summaries
Storia in 18 fonti
New drug nearly doubles survival rates in some pancreatic cancer patients, study says
New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
pbs.org
Pancreatic cancer is deadly and difficult to treat. A new pill could change that
The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
- ·
nbcnews.com
After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses
The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.
